Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Biosyngen Announces FDA Approval of Phase I/II Clinical Trials for BRL03
Monday, September 11, 2023Biosyngen has received clearance from the US FDA to proceed with an investigational new drug IND application for Phase III clinical trials of BRL a promising treatment for lung cancer gastric cancer and other advanced solid tumours
BioLineRx Receives FDA Approval of APHEXDA™ in Combination with Filgrastim (G-CSF)
Monday, September 11, 2023BioLineRx has received FDA approval for its drug APHEXDA motixafortide in combination with filgrastim GCSF to assist in mobilising haematopoietic stem cells for peripheral blood collection and subsequent autologous transplantation in patients with mu...
Biocytogen Pharmaceuticals and Myricx Bio Enter into Licence Agreement for ADC Development
Friday, September 08, 2023Biocytogen Pharmaceuticals and Myricx Bio have entered into an antibody evaluation option and licence agreement to collaborate on the development of antibody drug conjugates ADCs
Otsuka Pharmaceutical Collaborates with ShapeTX
Friday, September 08, 2023Otsuka Pharmaceutical and ShapeTX have announced a significant collaboration to develop intravitreallydelivered adenoassociated viruses AAVs for the treatment of ocular diseases with the option to expand the scope of their work to include additional...
SKAN Research Trust Collaborates with University of Cambridge
Thursday, September 07, 2023The SKAN Research Trust and the University of Cambridge have joined forces in an exciting collaboration aimed at advancing stem cell research
Clearmind Medicine Collaborates with Johns Hopkins University for Clinical Research
Thursday, September 07, 2023Clearmind Medicine has entered into a clinical trial agreement with Johns Hopkins University School of Medicine to conduct its Phase IIIa clinical trial of its proprietary MEAIbased CMND known as CMCMND
XtalPi Announces Partnership with Parthenon Therapeutics
Wednesday, September 06, 2023XtalPi and Parthenon Therapeutics have announced a collaboration aimed at the discovery of innovative therapeutic antibodies for the treatment of solid tumours
Zenas BioPharma Announces Collaboration Agreement with Bristol Myers Squibb
Wednesday, September 06, 2023Zenas BioPharma and Bristol Myers Squibb have entered into a strategic licence and collaboration agreement to develop and commercialise obexelimab for the treatment of autoimmune diseases in specific AsianPacific regions including Japan South Korea T...
ACM Biolabs Announced Positive Phase I Trial Results for SARS-CoV-2 Booster Vaccine
Tuesday, September 05, 2023ACM Biolabs has announced positive topline findings from the Phase I trial of ACM marking a significant milestone in their first clinicalstage development programme
FivepHusion Commences Deflexifol™ at Relapse Trial with Successful First Patient Treatment
Tuesday, September 05, 2023FivepHusion announced the treatment for the first patient in the Deflexifol at Relapse Trial DART marks a pivotal moment in the advancement of therapies for paediatric brain cancers
